NPCE — NEUROPACE INC (Healthcare >> Medical Devices)
NPCE FAQ
What is NPCE's ROE?
NEUROPACE INC reports a Return on Equity (ROE) of -149.20%.
What is NPCE's dividend yield?
NEUROPACE INC offers a dividend yield of 0.00%.
What is NPCE's Deepscope Quality Score?
Deepscope rates NPCE's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy NPCE?
Deepscope's AI Timing Score for NPCE is 70 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does NPCE belong to?
NEUROPACE INC is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.
|
USD 16.32
Price
0.44
(2.77%)
Day Change
|
|
|---|
NPCE Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 38) nhưng Thời điểm mua ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
ROE đang giảm đáng kể
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...
| Yếu tố Chất lượng |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 16.32 |
| PBV / Sector |
38.42 / 7.50
|
| Earning Per Share | -0.63 |
| PE / Sector |
N/A / 28.68
|
| PEG or PE/Growth / Sector |
N/A / 0.39
|
| Average 1M Daily Value |
3.51 M
GREAT
|
| Average 1W Daily Value |
2.96 M
GREAT
|
| Yếu tố Kỹ thuật |
|
28% |
| Sức khỏe tài chính |
|
37% |
| Khả năng kiếm lợi nhuận |
|
56% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-05 09:11:54 |
| Symbol | NPCE |
| Name | NEUROPACE INC |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 34.09 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 555.39 / 18,060.39 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 455 North Bernardo Avenue, Mountain View, CA, United States, 94043
Phone: 650 237 2700
Website: https://www.neuropace.com
Employees: 220
Sector: Healthcare >> Medical Devices
Description: NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
Google